# A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)

> **NCT03245333** · PHASE3 · UNKNOWN · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 120 (estimated)

## Conditions studied

- Small for Gestational Age Infant

## Interventions

- **DRUG:** Recombinant Human Growth Hormone Injection
- **DRUG:** Recombinant Human Growth Hormone Injection

## Key facts

- **NCT ID:** NCT03245333
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-12-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03245333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03245333, "A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03245333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*